Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy-Reference-Cited by-同舟云学术

Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy

Published:2001-05-15 Issue:10 Volume:166 Page:6212-6217
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Gyorffy Steve,Palmer Kay,Podor Thomas J.,Hitt Mary,Gauldie Jack

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. The use of adenoviral vectors for gene therapy and gene transfer in vivo

2. Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth

3. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating Oncolytic Adenovirus Immunotherapy by Driving Two Axes of the Immune System by Expressing 4-1BBL and CD40L;Human Gene Therapy;2022-01-06

2. New intratumoral immunotherapeutic approaches to inhibit the tumor growth and metastasis in breast cancer;Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives;2021

3. Viral gene therapy for breast cancer: progress and challenges;Expert Opinion on Biological Therapy;2017-06-12

4. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12;Immunotherapy;2016-02

5. Inhibition of breast tumor growth and abnormal angiogenesis in mice treated with endothelial cells and their progenitor mesenchymal stem cells derived from bone marrow;Neoplasma;2016